Cerebral vasculitis during FK 506 treatment in a liver transplant patient

Neurology

Volumn 50, Issue 4, 1998, Pages 1154-1157

  Pizzolato, G P ^a,b   Sztajzel, R ^a   Burkhardt, K ^a   Megret, M ^a   Borisch, B ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; OKT 3; STEROID; TACROLIMUS;

ADULT; ARTICLE; BRAIN VASCULITIS; CASE REPORT; DRUG INDUCED DISEASE; FEMALE; GRAFT REJECTION; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; NEUROTOXICITY; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0031922829     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.50.4.1154     Document Type: Article

References (10)

1. Menegaux F, Keeffe EB, Andrews BT, et al. Neurological complications of liver transplantation in adults versus pediatric patients. Transplantation 1994;58:447-450.
2. Wijdicks EFM, Wiesner RH, Dahlke LJ, Krom RAF. FK 506-induced neurotoxicity in liver transplantation. Ann Neurol 1994;35:498-501.
3. Stein DP, Lederman RJ, Vogt DP, Carey WD, Broughan TA. Neurological complications following liver transplantation. Ann Neurol 1992;31:644-649.
4. Patchell RA. Neurological complications of organ transplantation. Ann Neurol 1994;36:688-703.
5. Estol CJ, Pessin MS, Martinez AJ. Cerebrovascular complications after orthotopic liver transplantation: a clinicopathologic study. Neurology 1991;41:815-819.
6. Kumano K, Endo T, Koshiba K. Functional and morphological changes in rat kidney induced by FK 506 and its reversal by various vasodilators. Nippon Hinyokika Gakkai Zasshi (Japan) 1992;83:650-657.
7. Thiru S, Collier DSJ, Calne R. Pathological studies in canine and baboon renal allograft recipients immunosuppressed with FK 506. Transplant Proc 1987;19(suppl 6):98-99.
8. Demetris AJ, Fung JJ, Todo S, et al. Pathologic observations in human allograft recipients treated with FK 506. Transplant Proc 1990;22(suppl 1):25-34.
9. Mach-Pascual S, Samii K, Beris P. Microangiopathic hemolytic anemia complicating FK 506 (tacrolimus) therapy. Am J Hematol 1996;52:310-312.
10. Small SL, Fukui MB, Bramblett GT, Eidelman BH. Immunosuppression-induced leukoencephalopathy from tacrolimus (FK 506). Ann Neurol 1996;40:575-580.